The combined rapid antigen test for SARS-CoV-2/Influenza A+B/RSV/Adenovirus (nasopharyngeal swab) is a rapid chromatographic immunoassay intended for the qualitative detection of SARS-CoV-2 antigens (nucleocapsid protein), influenza A, influenza B, respiratory syncytial virus (RSV), and adenovirus present in the human nasopharynx.
✓ Simple Procedure: The test uses a rapid chromatographic method that requires only a few simple steps to obtain a result. Just add the sample and the buffer in the designated area and wait for the colored lines to appear.
✓ Quick Results : Results are available in just 15 minutes, allowing for rapid decision-making in medical emergency situations.
✓ Minimum Equipment: The test does not require expensive specialized equipment. The provided materials include test cassettes, droppers, and a swab, making the test accessible even in resource-limited environments.
| Download the datasheet |
| Download the manual |
|
Reference |
IRT-545 |
||||
|
Name of the product |
Rapid testmultipleForCOVID / INFLUENZA A&B / RSV / Adenovirus |
||||
|
Packaging |
20Kits per box, 40boxes per carton //800Kits in cartons 55*39.5*46cm,19kg/carton |
||||
|
Content of the box |
Test cassette - 20 |
||||
|
Data clinics MPCR reference method |
COVID Clinical sensitivity:96,4% Specificityclinical:99% Precision:98,2% |
FLU A Clinical sensitivity: 95% Clinical specificity: 99.1% Accuracy: 98.4%
|
FLU B Clinical sensitivity: 92.9% Clinical specificity: 99.1% Accuracy: 98.1%
|
VRS Clinical sensitivity: 94.3% Clinical specificity: 96.2% Accuracy: 95.9%
|
Adenovirus Clinical sensitivity: 96.9% Clinical specificity: 98.6% Accuracy: 98.4%
|